Children’s Tumor Foundation – Funding opportunities
The Children’s Tumor Foundation is dedicated to funding research that will prevent, reverse, or manage the complications of neurofibromatosis type 1 (NF1), and all types of schwannomatosis (SWN), including NF2-related schwannomatosis (NF2-SWN), formerly called neurofibromatosis type 2. As the leading non-governmental NF research funder in the US, CTF has historically acted as a ‘seed funder’ to provide funding especially to early-career NF researchers and to early-stage NF research, both of which require additional time and support before becoming eligible for larger governmental or industrial funding.
To facilitate the advancement of NF research and to better serve the NF community, CTF has established the Discovery Fund as a mechanism to support researchers and clinicians engaged in novel and fundamental NF investigations. The Discovery Fund encompasses the following award programs:
Young Investigator Award (YIA),
Drug Discovery Initiative (DDI),
Clinical Research Awards (CRA),
and Contract Awards.